CA2396883C - Non-invasive screening of skin diseases by visible/near-infrared spectroscopy - Google Patents
Non-invasive screening of skin diseases by visible/near-infrared spectroscopy Download PDFInfo
- Publication number
- CA2396883C CA2396883C CA2396883A CA2396883A CA2396883C CA 2396883 C CA2396883 C CA 2396883C CA 2396883 A CA2396883 A CA 2396883A CA 2396883 A CA2396883 A CA 2396883A CA 2396883 C CA2396883 C CA 2396883C
- Authority
- CA
- Canada
- Prior art keywords
- skin
- spectrum
- spectra
- nevi
- visible
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 208000017520 skin disease Diseases 0.000 title claims abstract description 46
- 238000004497 NIR spectroscopy Methods 0.000 title abstract description 5
- 238000012216 screening Methods 0.000 title abstract description 4
- 238000001228 spectrum Methods 0.000 claims abstract description 146
- 206010024217 lentigo Diseases 0.000 claims abstract description 36
- 201000003385 seborrheic keratosis Diseases 0.000 claims abstract description 28
- 238000000034 method Methods 0.000 claims abstract description 26
- 208000009621 actinic keratosis Diseases 0.000 claims abstract description 22
- 238000002329 infrared spectrum Methods 0.000 claims abstract description 11
- 208000009077 Pigmented Nevus Diseases 0.000 claims abstract description 8
- 201000002699 melanoma in congenital melanocytic nevus Diseases 0.000 claims abstract description 8
- 208000007256 Nevus Diseases 0.000 claims description 68
- 206010004146 Basal cell carcinoma Diseases 0.000 claims description 46
- 238000010521 absorption reaction Methods 0.000 claims description 21
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 21
- 201000010099 disease Diseases 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 150000002632 lipids Chemical class 0.000 claims description 9
- 201000001441 melanoma Diseases 0.000 claims description 8
- 108090000623 proteins and genes Proteins 0.000 claims description 8
- 102000004169 proteins and genes Human genes 0.000 claims description 8
- INGWEZCOABYORO-UHFFFAOYSA-N 2-(furan-2-yl)-7-methyl-1h-1,8-naphthyridin-4-one Chemical compound N=1C2=NC(C)=CC=C2C(O)=CC=1C1=CC=CO1 INGWEZCOABYORO-UHFFFAOYSA-N 0.000 claims description 7
- 108010002255 deoxyhemoglobin Proteins 0.000 claims description 7
- 108010064719 Oxyhemoglobins Proteins 0.000 claims description 6
- 208000035250 cutaneous malignant susceptibility to 1 melanoma Diseases 0.000 claims description 6
- 238000000491 multivariate analysis Methods 0.000 claims description 4
- 230000003902 lesion Effects 0.000 abstract description 32
- 230000003595 spectral effect Effects 0.000 abstract description 26
- 206010040882 skin lesion Diseases 0.000 abstract description 20
- 231100000444 skin lesion Toxicity 0.000 abstract description 20
- 238000000540 analysis of variance Methods 0.000 abstract description 17
- 238000004458 analytical method Methods 0.000 abstract description 14
- 230000003211 malignant effect Effects 0.000 abstract description 8
- 238000003745 diagnosis Methods 0.000 abstract description 7
- 239000000523 sample Substances 0.000 abstract description 7
- 238000007427 paired t-test Methods 0.000 abstract description 6
- 208000000453 Skin Neoplasms Diseases 0.000 abstract description 5
- 239000000835 fiber Substances 0.000 abstract description 5
- 230000037311 normal skin Effects 0.000 abstract description 5
- 238000001727 in vivo Methods 0.000 abstract description 3
- 210000000270 basal cell Anatomy 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 41
- 230000009102 absorption Effects 0.000 description 20
- 208000001126 Keratosis Diseases 0.000 description 17
- 238000001574 biopsy Methods 0.000 description 16
- 208000000471 Dysplastic Nevus Syndrome Diseases 0.000 description 15
- 208000004649 neutrophil actin dysfunction Diseases 0.000 description 15
- 210000001519 tissue Anatomy 0.000 description 12
- 206010028980 Neoplasm Diseases 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 238000004566 IR spectroscopy Methods 0.000 description 5
- 201000011510 cancer Diseases 0.000 description 5
- 238000004476 mid-IR spectroscopy Methods 0.000 description 5
- 230000000007 visual effect Effects 0.000 description 5
- 238000005259 measurement Methods 0.000 description 4
- 201000000849 skin cancer Diseases 0.000 description 4
- 206010041823 squamous cell carcinoma Diseases 0.000 description 4
- 108010054147 Hemoglobins Proteins 0.000 description 3
- 102000001554 Hemoglobins Human genes 0.000 description 3
- 206010039796 Seborrhoeic keratosis Diseases 0.000 description 3
- 230000002159 abnormal effect Effects 0.000 description 3
- 238000003748 differential diagnosis Methods 0.000 description 3
- 230000002068 genetic effect Effects 0.000 description 3
- 230000036074 healthy skin Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 238000004611 spectroscopical analysis Methods 0.000 description 3
- 102000018832 Cytochromes Human genes 0.000 description 2
- 108010052832 Cytochromes Proteins 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Chemical compound C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 2
- 206010064127 Solar lentigo Diseases 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 238000001413 far-infrared spectroscopy Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 238000006213 oxygenation reaction Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000000287 tissue oxygenation Effects 0.000 description 2
- 201000009030 Carcinoma Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 206010062805 Dysplastic naevus Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 108010089792 Hemeproteins Proteins 0.000 description 1
- 102000008015 Hemeproteins Human genes 0.000 description 1
- 102000036675 Myoglobin Human genes 0.000 description 1
- 108010062374 Myoglobin Proteins 0.000 description 1
- 206010033733 Papule Diseases 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 235000004789 Rosa xanthina Nutrition 0.000 description 1
- 241000109329 Rosa xanthina Species 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 238000000692 Student's t-test Methods 0.000 description 1
- 241000364021 Tulsa Species 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 208000011586 benign melanocytic skin nevus Diseases 0.000 description 1
- 206010004398 benign neoplasm of skin Diseases 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000002790 cross-validation Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000007489 histopathology method Methods 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 238000010150 least significant difference test Methods 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 238000004599 local-density approximation Methods 0.000 description 1
- 230000036210 malignancy Effects 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 238000003909 pattern recognition Methods 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 238000000985 reflectance spectrum Methods 0.000 description 1
- 230000004895 regional blood flow Effects 0.000 description 1
- 238000007390 skin biopsy Methods 0.000 description 1
- 230000008470 skin growth Effects 0.000 description 1
- 238000012306 spectroscopic technique Methods 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000000528 statistical test Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/44—Detecting, measuring or recording for evaluating the integumentary system, e.g. skin, hair or nails
- A61B5/441—Skin evaluation, e.g. for skin disorder diagnosis
- A61B5/444—Evaluating skin marks, e.g. mole, nevi, tumour, scar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0075—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by spectroscopy, i.e. measuring spectra, e.g. Raman spectroscopy, infrared absorption spectroscopy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/44—Detecting, measuring or recording for evaluating the integumentary system, e.g. skin, hair or nails
- A61B5/441—Skin evaluation, e.g. for skin disorder diagnosis
- A61B5/445—Evaluating skin irritation or skin trauma, e.g. rash, eczema, wound, bed sore
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7235—Details of waveform analysis
- A61B5/7264—Classification of physiological signals or data, e.g. using neural networks, statistical classifiers, expert systems or fuzzy systems
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Pathology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Medical Informatics (AREA)
- Biophysics (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Dermatology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15785799P | 1999-10-06 | 1999-10-06 | |
| US60/157,857 | 1999-10-06 | ||
| PCT/CA2000/001187 WO2001024699A2 (en) | 1999-10-06 | 2000-10-05 | Non-invasive screening of skin diseases by visible/near-infrared spectroscopy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2396883A1 CA2396883A1 (en) | 2001-04-12 |
| CA2396883C true CA2396883C (en) | 2011-04-12 |
Family
ID=22565569
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2396883A Expired - Lifetime CA2396883C (en) | 1999-10-06 | 2000-10-05 | Non-invasive screening of skin diseases by visible/near-infrared spectroscopy |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP1237479A2 (de) |
| AU (1) | AU782431B2 (de) |
| CA (1) | CA2396883C (de) |
| WO (1) | WO2001024699A2 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10346757A1 (de) * | 2003-10-06 | 2005-05-12 | Pe Diagnostik Gmbh | Verfahren zur Klassifikation von Messwerten in der medizinischen und biochemischen Analytik |
| US20110257492A1 (en) * | 2009-01-29 | 2011-10-20 | Tanja Maria Greve | Method for determining the state of a skin disorder using near infrared (nir) spectroscopy |
| EP2490586B1 (de) | 2009-10-23 | 2014-11-12 | Medespel Ltd | System für nichtinvasive gewebeuntersuchung |
| UA122145C2 (uk) | 2015-07-10 | 2020-09-25 | Інфектофарм Арцнейміттель Унд Консіліум Гмбх | Застосування гідроксиду калію в лікуванні актинічного кератозу |
| KR20210095145A (ko) | 2018-10-23 | 2021-07-30 | 에스테틱스 바이오메디컬, 인크. | 콜라겐 재생을 유도하는 방법, 장치 및 시스템 |
| CN119694573A (zh) * | 2024-12-18 | 2025-03-25 | 石家庄市第二医院 | 一种适用于糖尿病患者的智能化无创血糖检测方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5016173A (en) * | 1989-04-13 | 1991-05-14 | Vanguard Imaging Ltd. | Apparatus and method for monitoring visually accessible surfaces of the body |
| US6008889A (en) * | 1997-04-16 | 1999-12-28 | Zeng; Haishan | Spectrometer system for diagnosis of skin disease |
-
2000
- 2000-10-05 WO PCT/CA2000/001187 patent/WO2001024699A2/en not_active Ceased
- 2000-10-05 CA CA2396883A patent/CA2396883C/en not_active Expired - Lifetime
- 2000-10-05 AU AU77662/00A patent/AU782431B2/en not_active Ceased
- 2000-10-05 EP EP00967472A patent/EP1237479A2/de not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| AU782431B2 (en) | 2005-07-28 |
| CA2396883A1 (en) | 2001-04-12 |
| EP1237479A2 (de) | 2002-09-11 |
| WO2001024699A2 (en) | 2001-04-12 |
| AU7766200A (en) | 2001-05-10 |
| WO2001024699A8 (en) | 2001-10-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| McIntosh et al. | Towards non-invasive screening of skin lesions by near-infrared spectroscopy | |
| US7280866B1 (en) | Non-invasive screening of skin diseases by visible/near-infrared spectroscopy | |
| CA2398278C (en) | Visible-near infrared spectroscopy in burn injury assessment | |
| P. Santos et al. | Improving clinical diagnosis of early-stage cutaneous melanoma based on Raman spectroscopy | |
| Brown et al. | Advances in quantitative UV–visible spectroscopy for clinical and pre-clinical application in cancer | |
| US6493566B1 (en) | Classification system for sex determination and tissue characterization | |
| Farina et al. | Multispectral imaging approach in the diagnosis of cutaneous melanoma: potentiality and limits | |
| Zhu et al. | Diagnosis of breast cancer using diffuse reflectance spectroscopy: Comparison of a Monte Carlo versus partial least squares analysis based feature extraction technique | |
| Hosking et al. | Hyperspectral imaging in automated digital dermoscopy screening for melanoma | |
| CA2467407C (en) | Optical transillumination and reflectance spectroscopy to quantify disease risk | |
| JP2013500464A (ja) | 皮膚黒色腫の赤外イメージング | |
| Kanemura et al. | Assessment of skin inflammation using near-infrared Raman spectroscopy combined with artificial intelligence analysis in an animal model | |
| Nunes et al. | FT‐Raman spectroscopy study for skin cancer diagnosis | |
| McIntosh et al. | Near-infrared spectroscopy for dermatological applications | |
| CA2396883C (en) | Non-invasive screening of skin diseases by visible/near-infrared spectroscopy | |
| Shirkavand et al. | Application of optical spectroscopy in diagnosing and monitoring breast cancers: A technical review | |
| Tosi et al. | FTIR microspectroscopy of melanocytic skin lesions: a preliminary study | |
| EP3351162A1 (de) | Computerimplementiertes verfahren, system und computerprogrammprodukte zur charakterisierung einer hautverletzung | |
| Takiwaki et al. | Analysis of the absorbance spectra of skin lesions as a helpful tool for detection of major pathophysiological changes | |
| Khazaei et al. | Visible-short wavelength near infrared hyperspectral imaging coupled with multivariate curve resolution-alternating least squares for diagnosis of breast cancer | |
| RU2847903C1 (ru) | Способ оптической биопсии новообразований кожи на основе синхронного анализа рамановского и флуоресцентного сигналов отраженного лазерного излучения | |
| Dahlstrand et al. | Dybelius Ansson C, Memarzadeh K, Reistad N, Malmsjö M (2019) Extended-wavelength diffuse reflectance spectroscopy with a machine-learning method for in vivo tissue classification | |
| Calin et al. | 640 A hyperspectral index-based approach for in vivo automatic detection of skin tumors from hyperspectral images | |
| Matveeva | Extraction of Informative Features for Optical Biopsy Data Analysis | |
| Kang et al. | Methods to Study Vitiligo: Noninvasive Techniques and In Vivo Reflectance Confocal Microscopy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |